Delivery Order SPE2DB20D1109-SPE2DB23FM99N
- Not listed
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $11,783.89 and an ultimate completion date of November 16, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
- This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,074.45, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $10,800.64. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $28,236.23 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on October 24, 2023, with a completion date of October 25, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $10,944.65, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,974.54 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 6, 2023 with a completion date of November 7, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm-fixed-price delivery order valued at $7,408.48, with a completion date of February 17, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S, a prescription medication, to the Defense Logistics Agency (DLA). The $3,296.03 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 6, 2023, with a completion date of January 9, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $10,034.72, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a period of performance through December 4, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a total potential...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $28,867.86, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price and has an ultimate completion date of March 11, 2024. This award is not designated as a set-aside. Amerisourcebergen Drug...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FM99NDelivery Order
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $13,634.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. This particular delivery order has a completion date of November 9, 2022 and is priced on a firm fixed-price basis. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 11/8/22 |